I want to vary my product to include a new dose rate, frequency, route of administration or application method (vet products only)

Varying the dose, the frequency of administration, or the route of administration of a veterinary medicine product can be done through either:

  • Item 12: No data of a technical nature is required. This type of application is used when risks are equivalent to a registered product not subject to data protection.
  • Item 14: Technical modular application. All applications not meeting the requirements of Item 12.

Is a technical assessment required for my proposed variation?

Most variations of this type are likely to be made as Item 14 applications, as they will require a technical assessment.

Variations that don’t require a technical assessment to satisfy the safety, efficacy and trade criteria can be processed under a non-technical fixed fee variation (Item 12). These applications are generally supported through reference to statements which are already approved on another registered product (reference product).

In these cases the APVMA will apply the same approach as conducted for Items 6, 7 and 8 for the purposes of defining if the reference product is either the same or closely similar.

The product when compared to the reference product must meet the following criteria:

  • Same active constituent(s)
  • Same concentration of active(s)
  • Non-active constituents are equivalent substances, at the same or equivalent concentrations or differences are minor and not expected to have adverse implications on product quality or biological activity in terms of efficacy, safety or residues
  • The specifications and properties are the same or equivalent or differences are minor and are not expected to have adverse implications for product quality or biological activity in terms of efficacy, safety or residues
  • Same dose form and formulation type
  • Same use pattern and instructions
  • Label claims are the same
  • Reference product information is not subject to limit on use of information or the applicant has obtained consent from the owner to use the data from the reference product

Limits on use (data protection): Where there are limits on use of information on the reference product, written consent from the authorising party is required when access to the information is necessary to determine the application.

Where the reference product does not fully support all risk areas or the product is subject to limits on use and additional data is being provided to satisfy the safety, efficacy or trade criteria these applications should be lodged as Item 14 applications.

Which application form do you need?

Application guidance

Specific information on completing this application form is provided below. Once you are familiar with the content you can proceed to ‘Start an application’ at the button below.

Please note: the fees referenced in this tailored guidance take effect from 1 July 2020. For a list of fees and charges up to 30 June 2020, please view the timeframe and fees section on our website.

Legislation

Framework

The Agricultural and Veterinary Chemicals (Administration) Act establishes the APVMA as an independent statutory authority of the Commonwealth, responsible for the regulation and control of agvet chemicals in Australia up to the point of retail sale. This Act contains all of the internal details of the establishment of and the functions and powers of the APVMA. It also contains provisions controlling the import and export of chemicals.

The Agricultural and Veterinary Chemicals Act contains the constitutional and other legal provisions that enable the Agvet Code to have effect.

The Agricultural and Veterinary Chemicals Code Act, among other things, contains the detailed provisions allowing the APVMA to evaluate, approve or register and review active constituents and agricultural and veterinary chemical products (and their associated labels); and to issue permits and to license the manufacture of chemical products. It also contains provisions for controls to regulate the supply of chemical products; and provisions ensuring compliance with, and for the enforcement of, the code.

The Agricultural and Veterinary Chemicals Code Regulations 1995 prescribe detailed provisions of the Agvet Code.

The Agricultural and Veterinary Chemicals Code (Application Requirements) Instrument 2014 sets out the information that must be contained in, or accompany an, application under the Agvet Code.

Section 6A of the Agricultural and Veterinary Chemicals Code Act states that the APVMA may make guidelines. The APVMA has a number of guidelines which fall under this, for example:

Statutory criteria

In addressing the criteria, the applicant may provide information, or valid scientific argument that might address a specific criterion. The following sections of the Agvet Code provide definitions for meeting the criteria:

An active constituent or chemical product meets the safety criteria if use of the constituent or product, in accordance with any instructions approved, or to be approved, by the APVMA for the constituent or product or contained in an established standard:

a) is not, or would not be, an undue hazard to the safety of people exposed to it during its handling or people using anything containing its residues; and
b) is not, or would not be, likely to have an effect that is harmful to human beings; and
c) is not, or would not be, likely to have an unintended effect that is harmful to animals, plants or things or to the environment.

To satisfy the S 5A criteria, the APVMA considers chemistry and manufacture, toxicology (including poison scheduling, residues, work health and safety, environment and target safety).

A chemical product meets the efficacy criteria if use of the product, in accordance with instructions approved, or to be approved, by the APVMA for the product or contained in an established standard, is, or would be, effective according to criteria determined by the APVMA by legislative instrument.

A chemical product meets the trade criteria if use of the product, in accordance with instructions approved, or to be approved, by the APVMA or contained in an established standard, does not, or would not, unduly prejudice trade or commerce between Australia and places outside Australia.

In approving a label for a container for chemical products, the APVMA must be satisfied that the label contains adequate instructions. This allows the APVMA to ensure that the risks of using the agvet chemical product are adequately mitigated through appropriate instructions.

The APVMA’s Agricultural Labelling Code and Veterinary Labelling Code also contain further labelling requirements that ensure a standard layout, eligibility and further help in mitigating the risk of using agvet chemical products when used in accordance with the label instructions.

Varying relevant particulars and conditions

The APVMA must vary the relevant particulars or conditions if it is satisfied application requirements and statutory criteria have been met (Section 29 of the Agvet Code).

Section 20(1)(c) of the Agvet Code defines relevant particulars in relation to the registration of a chemical product as:

  • the distinguishing number
  • any instructions for the use of the product
  • any other particulars prescribed by the regulations.

Other particulars for chemical products prescribed by the regulations are:

(a)  the distinguishing name of the chemical product
(b)  the constituents of the chemical product
(c)  the concentration of each constituent of the chemical product
(d)  if possible, the composition and purity of each active constituent of the chemical product
(da)  the formulation type for the chemical product
(db)  the net contents for the chemical product
(e)  identifying information for the holder of the registration of the chemical product
(g)  the name of each manufacturer of the chemical product
(h)  the address of each site at which the chemical product is manufactured by the manufacturer
(j)  the date of entry of these particulars in the Register of Chemical Products
(k)  identifying information for any nominated agent for the registration.

The Agvet Code defines particulars in relation to approval of a label as:

(i) the name of the person who applied for the approval as the holder of the approval
(ii) the name of any nominated agent for the approval
(iii) the distinguishing number
(iv) the instructions and any particulars that are to be contained on the label
(iva) any other particulars prescribed by the regulations
(v) any conditions of the approval imposed by the APVMA.

Other particulars for labels prescribed by the regulations are:

Regulation 17(1)

a) the appropriate signal words required by the current Poisons Standard
b) the name of the chemical product that is to appear on a label for containers of the chemical product
c) the name of each active constituent of the product
d) the proportion of each active constituent of the product
e) the name of each constituent for the product that is

a. not an active constituent; and
b. classified as a poison in the current Poisons Standard

f) the proportion of each constituent referred to in paragraph (e)
g) the net contents of the product
h) particulars determined by the APVMA CEO under subregulation (2).

Regulation 17(2)

For paragraph 6(2)(c) of the Act, the APVMA CEO may determine additional particulars to be placed on a label for a product.

Regulation 17(3)

a) identifying information for the holder of the approval
b) identifying information for any nominated agent for the approval
c) the distinguishing name of the chemical product that is prescribed under paragraph 16(a) and entered in the Register
d) the distinguishing number of the chemical product that is entered in the Register.

Conditions are:

a) the conditions prescribed by the regulations (whether or not the conditions are prescribed at the time the constituent, product or label is approved or registered); and
b) any conditions imposed on the approval or registration as the APVMA thinks appropriate.

Application requirements

Section 8A of the Agvet Code provides the definition of 'meets the application requirements'.

Parts 2 and 4 of the Agricultural and Veterinary Chemicals Code (Application Requirements) Instrument sets out the information that must be contained in, or accompany an, application under the Agvet Code.

Guidelines

6A of the Agvet Code states that the APVMA may make written guidelines for performing its functions and exercising its powers under this Code.

The APVMA has designed guidelines to help inform the APVMA and applicants as to the modules, data and information that will apply for different types of applications. The guidelines are not the law. The APVMA will have regard to it, but from time to time may depart from it when determining the modules, data and information are necessary for a particular application. The APVMA has a number of guidelines which fall under this, for example:

Applications may be withdrawn

Section 8D of the Agvet Code states that at any time after the application is made and before it is determined, the applicant may withdraw it by giving the APVMA written notice of the withdrawal signed by the applicant.

Timeframe and fees

Timeframe and fees

A technical variation is a modular application type, therefore the fees and timeframe are variable according to the assessments necessary. Legislative timeframes commence once the application has passed preliminary assessment and fees have been paid.

Applications to include a new dose rate or frequency must satisfy the statutory criteria of safety, efficacy and trade. Depending on the extension being sought, one or more of the following Module types 2 to 10 will require the provision of supporting data and/or scientific argument. Where an applicant considers that an assessment of any particular module is not necessary justification must be provided.

Module type

Module level

Timeframe

Fee

1: Preliminary assessment

1.0

Up to one month

$902

2: Chemistry

No assessment required as the product is currently registered and no change is proposed to the product formulation.

3: Toxicology

No assessment required as the formulation and route of exposure are not changing.

4: Toxicology – Poison scheduling

No assessment required if appropriate scheduling is already in place.

5: Residues and trade (if required)

Assessment required if the change in dose requires consideration of MRLs, WHPs or trade implications

5.2 or

5.4

8 months

4 months

$11 149

$7 465

6: Work health and safety (if required)

Assessment required for a new application method or where worker exposure may be different to the existing use.

6.2

6.3

7 months

4 months

$3 185

$3 913

7: Environment (if required)

May be required if the risk to the environment might change as a result of the changed dose or application frequency

7.2

7 months

$7 659

8: Efficacy and safety

Required to show the new dose or frequency is safe and effective for the target species. Module 8.3 is appropriate when only scientific argument or bioequivalence data is required to show safety and efficacy.

8.2 or

8.3

4 months

3 month

$1 950

$1 160

9: Non-food trade (if required)

9.0

6 months

$1 175

10: Special data (if required)

10.2 (antibiotic)

10.3 (GMO)

7 months

7 months

$Nil

$Nil

11: Finalisation

11.1 or
11.2

3 months
2 months

$8 110
$3 090

12: Limits on use (data protection)

12.0

N/A

$460

Examples

Scenario

Modules

Timeframe

Fee

Scenario 1Increase the dose of a euthanasia solution.

1, 8.2, 11.2, 12

6 months

9 months (extended assessment period)

$6 402

Scenario 2Change the dose and frequency of an intravenous antibiotic.

1, 8.2, 11.2, 12

6 months

9 months (extended assessment period)

$6 402

Scenario 3Variation to increase the dose rate for a sheep drench.  

1, 5.4, 8.2, 11.2, 12

6 months

9 months (extended assessment period

$13 867

Scenario 4Variation to change the duration of immunity on a vaccine product.

1, 8.2, 11.2, 12

6 months

9 months (extended assessment period)

$6 402

Scenario 5Variation to the application method to use hand jetting in a product approved for automatic jetting. 

1, 6.2, 8.3, 11.2, 12

9 months

13 months (extended assessment period)

$8 797

Scenario 6Variation to the route of administration from intravenous injection to intramuscular injection.

1, 8.2, 11.2, 12

6 months

9 months (extended assessment period)

$6 402

Pre-application assistance

Pre-application assistance is available to give applicants advice on the requirements of an application before submission.

Modules

The APVMA has developed a guideline for module descriptors to provide guidance as to the modules that will apply for different types of applications. The APVMA will have regard to it, but may depart from it, when determining which modules are necessary on a case by case basis. The guideline is not the law.

An application to vary a dose or frequency of application must satisfy the statutory criteria of safety (Section 5A), efficacy (Section 5B), and trade (Section 5C). However, the amount of new information or data required will vary depending upon how significant the change is, and what new assessments are necessary.

Module 1: Preliminary assessment

Preliminary assessment is an initial examination of the application for administrative completeness. It is an administrative check that the form and content of the application meet the application requirements. In other words, the outward look of the application and its accompanying information appears to be in order and complete. It is not a completeness check of the technical aspects of your submission.

Applies to all modular application items.

Module 5: Residues and trade

Residues assessment includes the establishment of residues definition, maximum residue limits (MRLs), and withholding periods (WHPs), and the assessment of the trade implications including the establishment of any export intervals (EIs).

There are general guidelines for both Residues Part 5A and Overseas trade Part 5B available and you should consider any of the specific guidelines which relate to your product type or extension of use.

5.2: Residues—level 2

A reduced residue assessment (Module 5.2) applies to applications requiring assessment of the residues and trade implications for a new food species or a variation to the dose rate or frequency of application to a food species and where a change to established MRLs are required.

c. Variation to change the dose rate or frequency of application to food species and where a change to established MRLs are required.

Module level Module type Timeframe Fee
5.2 Residues and trade 8 months $11 149

5.4: Residues—level 4

A limited residue assessment (Module 5.4) applies to variations which involve review of WHPs and trade implications including:

b. A variation which involves review of WHPs and trade implications including:

  1. a minor formulation change;
  2. changes to a label which have potential risk of residues where no change to the established MRLs is required; or
  3. residues assessment that is not referred to in Module 5 above including establishing or amending Table 5 entries.
Module level Module type Timeframe Fee
5.4 Residues and trade—limited residue assessment 4 months $7 465

Module 6: Work health and safety

A work health and safety (WHS) assessment is required where there is a change to human exposure. Changes to human exposure can occur when extending into new animal species or situations. These exposures include changes such as application dose, route of administration, worker rates and practices including post application activities. The change in exposure may result in a change to the entry in the first aid instructions and safety directions (FAISD) handbook including changes to personal protective equipment (PPE) and re-entry into treated areas or handling of treated animals following application.

Several types of applications for registration of a new product do not require WHS assessment, as the product is not normally associated with any potential risks to human health. Where, however, there is any such risk, an appropriate WHS assessment is required. The types of application for products which do not normally require WHS assessment are as follows:

a. Applications for a permit for a product, registration of a new product or variation of the particulars or conditions of a registered product that are:

  1. animal therapeutics and mineral and nutritional supplements in tablet, capsule, slow release bolus or skin implant form
  2. animal therapeutics which have Therapeutic Goods Administration approval for direct administration to humans and the use pattern indicates low worker exposure potential (that is, not mob or flock treatments with a drench or a pour on, or as a feed additive, or other equivalent use pattern, as these have high worker exposure potential)
  3. mineral, vitamin and nutritional supplements for a single animal or a small number of animals and are administered directly to the animal or into daily food or water
  4. vitamins; digestive enzyme supplements; electrolytes; iron and haematopoietic agents; tonics and stimulants; or preservatives
  5. micro organism and enzyme products for use in non-food species
  6. stockfood additives and nutrition or metabolism products (other than those listed in this paragraph) with established safety directions, which are directly applicable to the concentration of the additive and the form in which it is to be used
  7. animal bacterial and viral vaccines.

6.2: Work health and safety—level 2

A reduced work health and safety assessment (Module 6.2) is required when the application involves a new species or situation or a new application method.

c. A variation which involves:

  1. a change in use pattern to include a new species or situation; or
  2. a new application method.
Module level Module type Timeframe Fee
6.2 Workplace health and safety 7 months $3 185

6.3: Work health and safety—level 3

Work health and safety—level 3 (Module 6.3) is required where the application involves a change or reassessment of user safety directions and/or re-entry or re-handling statements.

b. A variation that is not referred to in Module 6.2 above, that requires a WH&S assessment due to a varied exposure scenario (for example, to consider re-entry/re-handling statements and/or safety directions).

Module level Module type Timeframe Fee
6.3 Workplace health and safety 4 months $3 913

Module 7: Environment

Where there is any potential risk to the environment, an appropriate environmental assessment is required. This assessment will take into account the expected volume of use; the expected exposure, behaviour and fate of the active constituent/s; and the potential harmful effects on flora and fauna; resulting from use of the product.

In situations where the proposed use pattern does not change the risk to the environment, and this can be determined without further assessment, no environmental assessment is required.

7.2: Environment—level 2

b. Variations of an approval which involves:

  1. a new herd animal or new situation;
  2. changes to application method; or
  3. increase in application rate, dose or frequency for an existing use pattern.
Module level Module type Timeframe Fee
7.2 Environment 7 months $7 659

Module 8: Efficacy and safety

Efficacy assessment ensures that the product works as described on the label, when used according to label directions.

Safety assessment ensures that the product is safe to use on or in the target crop or animal, when used according to label directions.

An efficacy and safety assessment may include assessing the effect of the product on target and non-target animals, effects of residues and pharmacologic studies.

8.2: Efficacy and safety—level 2

A reduced efficacy and safety assessment (Module 8.2) applies for:

c. A variation which involves:

  1. use on a new pest or disease or for a new purpose in the same food species or companion animal; or
  2. a change to the dosage or administration instructions—including treatment number, frequency, duration, dose, and route of administration—in the same food species or companion animal.
Module level Module type Timeframe Fee
8.2 Efficacy and target safety 4 months $1 950

8.3: Efficacy and safety—level 3

A limited efficacy and safety assessment (Module 8.3) applies for:

h. A variation which involves:

  1. use in a non-food species (other than a dog, cat or horse): or
  2. where only bioequivalence or pharmaceutical equivalence is required to demonstrate the efficacy and safety.
Module level Module type Timeframe Fee
8.3 Efficacy and target safety 3 months $1 160

Module 9: Non-food trade

The non-food trade module is applied to applications involving trade risks not related to food residues.

a. A product involving trade risks not related to food residues, including:

  1. residues in wool and fibre;
  2. genetically modified produce;
  3. the presence of disease or seropositive testing to exotic or notifiable agents;
  4. hormonal growth promotants and other endocrine substances; or
Module level Module type Timeframe Fee
9 Non-food trade 6 months $1 175

Module 10: Special data assessment

This module applies to all applications for registration of a new chemical product or variation of the particulars or conditions of a registered chemical product, which contain active constituents that are new antibiotic substances or which contain genetically modified organisms (GMOs) require a Module 10 assessment.

10.2: Special data—level 2

a. A product containing an approved antibiotic active constituent and which is expected to result in significantly increased volume of use of the approved antibiotic active constituent or an increased risk to public health including:

  1. a variation of use to a new food species, or a dog or a cat;
  2. a variation of use to another major group within the same food species (for example: broiler chickens to layers; beef cattle to dairy cattle); or
  3. a change in dosage form or use pattern (for example: from use in individual animals to mass medication).
Module level Module type Timeframe Fee
10.2 Antimicrobial resistance 7 months $Nil

Module 11: Finalisation

This module encompasses administrative steps relating to the finalisation of the application. This can include public consultation, entering the required information into the relevant record or register, and the completion of the technical evaluation and risk assessment report outlining the evaluation of the application.

11.1: Finalisation—level 1

b. A variation where three or more modules between 2.1 to 10.3 apply.

Module level Module type Timeframe Fee
11.1 Finalisation 3 months $8 110

11.2: Finalisation—level 2

b. A variation where fewer than three modules between 2.1 to 10.3 apply.

Module level Module type Timeframe Fee
11.2 Finalisation 2 months $3 090

Module 12: Limits on use of information

Module 12 relates to the protection, handling and use of information provided to the APVMA. In general, the APVMA must not use information given to it in connection with one application to assess or make a decision on another application, except in specific circumstances. These circumstances include, but are not limited to, where the applicant has given consent for the information to be shared or in an emergency situation; see CCI Practice Statement. This ‘limited use data’ includes information such as reports, studies and scientific arguments that may or may not include confidential commercial information. The applicant can request the module at the time an application is lodged, but the APVMA may also include it once an assessment of the application is undertaken.

Module level Module type Timeframe Fee
12 Data protection N/A $460

What you need to provide

To meet the application requirements you will need to provide:

  • a completed online application form
  • the application fee plus any amount that is due to the APVMA
  • supporting information to demonstrate that the proposed variation will be efficacious and will not cause unintended harm
  • an information list
  • consent for use (if any of the information provided is subject to limits on use)
  • an e-label.

Completed online application form

First time applicants will need to complete an online services new user access form to access APVMA online services.

If you are unfamiliar with the application process you may wish to consult the guide to completing an online application.

The application fee

You may choose to:

  • pay the total fee on submission or
  • pay the preliminary assessment fee of $902 on submission and the remaining balance once the application has been accepted.

You can choose to pay by credit card, electronic funds transfer or BPAY.

Note: To meet the application requirements you must pay any amount (including an amount in respect of a tax or penalty) that is due and payable by you to the APVMA (including under a law of another jurisdiction or the agvet law).

Supporting information

The application must contain, or be accompanied by, information relevant to whether the chemical product meets the safety and efficacy criteria, but only to the extent that the variation proposed affects whether the product meets the safety, efficacy and trade criteria. 

Applicants should include an explanation of why they believe supporting information is not required if they choose not to provide it with the application.

Relevant data for module levels—veterinary chemical products sets out the data that may be relevant to particular assessment modules detailed in the Agvet Regulations. This list is not exhaustive and is only intended to provide you with guidance in putting your application together.

Information list

It is an application requirement that all applications for approval, registration or variation include a short description of each item of information contained in, or accompanying the application—an information list.

Any document (information) submitted with the application constitutes information for the purposes of the information list. This includes supporting information, such as consent for use letters, manufacturer's declarations, MSDS, certificates of analysis, GMP certificates and other such documentation, in addition to the scientific studies or data that may be submitted to specifically address the safety, trade and efficacy criteria.

The online application form contains fields to assist applicants in entering the information required to generate the information list.

Note: Information lists are published, including details of the holders of the information. Applicants should take care not to inadvertently divulge confidential commercial information (CCI) when creating the list.

Electronic label (e-label)

The APVMA must have regard to certain matters or details in order to satisfy itself that a label meets the labelling criteria and approve the label (sections 5D and 14 of the Agvet Code). Applicants must use the e-label template to submit the label details that the APVMA must take into account.

Introduction to preparing a label and the label approval process provides more detailed information.

Examples

Scenario 1: Variation to increase the dose of a euthanasia solution

Objective

An application is made to increase the dose of an intravenous (IV) product used for the euthanasia of various animals. The dose is being increased from 2 mg/kg to 3 mg/kg. 

The applicant has nominated a reference product (which has no relevant protected data) and provided scientific argument as how the product will continue to meet the statutory criteria once the variation is made.

The applicant has provided an updated label with the new dose rate.

Application type

This application is considered under a technical variation (Item 14) as evidence is needed to demonstrate that product’s capacity to meet the safety (Section 5A) and efficacy (Section 5B) criterion will not be affected by the increased dosage.

The following table examines each assessment module and provides an explanation of what modular assessments, levels, timeframe and associated fees are likely to apply to this extension. Modules 1, 11 and 12 are mandatory modules for this application.

Module type

Module level

Timeframe

Fee

1: Preliminary assessment

1.0

Up to one month

$902

2: Chemistry

No assessment required as the product is currently registered and no change is proposed to the product chemistry.

3: Toxicology

No assessment required as the product is currently registered and relevant health standards are already established. No new information provided.

4: Toxicology – Poison scheduling

No assessment required if appropriate scheduling is already in place.

5: Residues and trade

No assessment required as the increased dose is related to a non-food use.

6: Work health and safety

No assessment is required as the increased dose does not change the risks previously assessed for human health.

7: Environment

No assessment is required as the increased dose does not change the risks previously assessed for the environment.

8: Efficacy and safety

Assessment is required to evaluate the scientific argument in comparison to the reference product information to support the increased dose. 

8.2

4 months

$1 950

9: Non-food trade

No assessment required as there are no changes to the product risks to non-food trade.

10: Special data

No assessment required as the product is not an antibiotic or a GMO.

11: Finalisation

11.2

2 months

$3 090

12: Limits on use (data protection)

12.0

N/A

$460

Total

 

6 months

$6 402

Scenario 2: Variation to change the dose and dosage frequency for an antibiotic product

Objective

An application is made to change the dose and frequency of an intravenous injection antibiotic product used in horses.

Current label instructions

Proposed new label instructions

Horses: 2.5 mg/kg twice daily by intravenous injection.

Horses: 8.0 mg/kg once daily by slow intravenous injection.

The applicant has provided safety, efficacy and pharmacokinetics data to support the application.

An updated label with the new dosing regime has also been provided.

Application type

This application is considered under a technical variation (Item 14) as evidence is needed to demonstrate that product will continue to meet the safety and efficacy criteria.

The following table examines each assessment module and provides an explanation of what modular assessments, levels, timeframe and associated fees are likely to apply to this extension. Modules 1, 11 and 12 are mandatory modules for this application.

Module type

Module level

Timeframe

Fee

1: Preliminary assessment

1.0

Up to one month

$902

2: Chemistry

No assessment required as the product is currently registered and no change is proposed to the product chemistry.

3: Toxicology

No assessment required as the product is currently registered and relevant health standards are already established. No new information provided.

4: Toxicology – Poison scheduling

No assessment required if appropriate scheduling is already in place.

5: Residues and trade

An assessment is not required as the use is in a non-food species. The label already has a restraint to prevent use in food producing animals.

6: Work health and safety

No assessment is required as human exposure is not expected to change as a result of the variation to the dose.

7: Environment

No assessment is required as the overall exposure to the environment is not expected to change.

8: Efficacy and safety

An assessment is required to ensure the change in dose is safe and efficacious for horses

8.2

4 months

$1 950

9: Non-food trade

No assessment required as there are no changes to product risks to non-food trade.

10: Special data

No assessment required as there is no increased risk of antibiotic resistant from the changed use pattern.

11: Finalisation

11.2

2 months

$3 090

12: Limits on use (data protection)

12.0

N/A

$460

Total

 

6 months

$6 402

Scenario 3: Variation to increase the dose rate for a sheep drench product and to increase the interval between treatments

Objective

An application is made to increase the dose rate of a sheep drench product to allow a claim that the product will remain effective for a longer period of time between treatments.

The applicant has provided data on the efficacy and safety of the higher dose. Meat and milk WHP and ESI will need to be amended and residues data has been submitted at the new dose and frequency. No changes to MRLs are proposed.

An updated label with the new dose rate and dosing interval has also been provided.

Application type

This application is considered under a technical variation (Item 14) as evidence is needed to demonstrate that product will continue to meet the safety and efficacy criteria.

The following table examines each assessment module and provides an explanation of what modular assessments, levels, timeframe and associated fees are likely to apply to this extension. Modules 1, 11 and 12 are mandatory modules for this application.

Module type

Module level

Timeframe

Fee

1: Preliminary assessment

1.0

Up to one month

$902

2: Chemistry

No assessment required as the product is currently registered and no change is proposed to the product chemistry.

3: Toxicology

No assessment required as the product is currently registered and relevant health standards are already established. No new information provided.

4: Toxicology – Poison scheduling

No assessment required if appropriate scheduling is already in place.

5: Residues and trade

An assessment is required to review WHPs and ESIs at the new dose rate and frequency.

5.4

4 months

$7 465

6: Work health and safety

No assessment required. Due to the method of application (syringe), worker exposure is not expected to change.

7: Environment

No assessment is required as the overall exposure to the environment is not expected to change.

8: Efficacy and safety

Assessment is required to assess if the new dose and dosing interval is safe and effective for the target animal

8.2

4 months

$1 950

9: Non-food trade

No assessment required as there are no changes to product risks to non-food trade.

10: Special data

No assessment required as the product is not GMO or an antibiotic

11: Finalisation

11.2

2 months

$3 090

12: Limits on use (data protection)

12.0

N/A

$460

Total

 

6 months

$13 867

Scenario 4: Changing the duration of immunity on a vaccine product

Objective

An application is made to vary a vaccine product for use in dogs to amend the dosage and administration section of the label including the duration of immunity. The proposed change will require a booster vaccination after 3 years instead of 12 months.

The applicant has submitted a safety and efficacy study with the new dose regime as well as scientific argument.

An updated label has been provided.

Current label instructions

Proposed new label instructions

Revaccination:

An annual booster is recommended

Revaccination:

A single dose vaccine should be given at intervals of up to 3 years following the primary vaccination program.

Application type

This application is considered under a technical variation (Item 14) as evidence is needed to demonstrate that product will continue to meet the safety and efficacy criteria.

The following table examines each assessment module and provides an explanation of what modular assessments, levels, timeframe and associated fees are likely to apply to this extension. Modules 1, 11 and 12 are mandatory modules for this application.

Module type

Module level

Timeframe

Fee

1: Preliminary assessment

1.0

Up to one month

$902

2: Chemistry

 

No assessment required as the product is currently registered and no change is proposed to the product chemistry.

3: Toxicology

 

No assessment required as the product is currently registered and relevant health standards are already established. No new information provided.

4: Toxicology – Poison scheduling

No assessment required if appropriate scheduling is already in place.

5: Residues and trade

No assessment required as the product is for use in dogs.

6: Work health and safety

No assessment required as the user risk has not changed.

7: Environment

No assessment is required as the overall exposure to the environment is not expected to change.

8: Efficacy and safety

Assessment is required to ensure the change in vaccination schedule is safe and efficacious for dogs.

8.2

4 months

$1 950

9: Non-food trade

 

No assessment required as there are no changes to product risks to non-food trade.

10: Special data

Not required.

11: Finalisation

11.2

2 months

$3 090

12: Limits on use (data protection)

12.0

N/A

$460

Total

 

6 months

$6 402

Scenario 5: Variation to the application method to use hand jetting in a product approved for automatic jetting

Objective

An application is made to vary a fly and lice control product in sheep to provide directions for use by hand jetting. The product is registered for this use by automatic jetting.

The applicant has provided scientific argument that the proposed application method is as effective and safe as the approved application method.

The applicant has provided an updated label with the instructions.

Application type

This application is considered under a technical variation (Item 14) as evidence is needed to demonstrate that product’s capacity to meet the safety (Section 5A) criterion will not be affected by the increased application rate.

The following table examines each assessment module and provides an explanation of what modular assessments, levels, timeframe and associated fees are likely to apply to this extension. Modules 1, 11 and 12 are mandatory modules for this application.

Module type

Module level

Timeframe

Fee

1: Preliminary assessment

1.0

Up to one month

$902

2: Chemistry

No assessment required as the product is currently registered and no change is proposed to the product chemistry.

3: Toxicology

No assessment required as the product is currently registered and relevant health standards are already established. No new information provided.

4: Toxicology – Poison scheduling

No assessment required if appropriate scheduling is already in place.

5: Residues and trade

No assessment required as the application rate is not changing.

6: Work health and safety

Assessment required to determine exposure for users and consider existing safety directions and PPE. No additional data is required.

6.2

7 months

$3 185

7: Environment

No assessment is required as the changed application method does not increase the environmental risk.

8: Efficacy and safety

An assessment is required to show efficacy and safety by the alternate application method (scientific argument provided).

8.3

3 months

$1 160

9: Non-food trade

No assessment required as there are no changes to the product risks to non-food trade.

10: Special data

No assessment required as the product is not an antibiotic or a GMO.

11: Finalisation

11.2

2 months

$3 090

12: Limits on use (data protection)

12

N/A

$460

Total

 

9 months

$8 797

Scenario 6: Variation to the route of administration for an anaesthetic for companion animals from intravenous injection to intramuscular injection

Objective

An application is made to change the route of administration for an anaesthetic from intravenous to intramuscular.

The applicant has provided safety, efficacy and pharmacokinetics data to support the application.

An updated label with the new instructions for intramuscular injection has also been provided.

Application type

This application is considered under a technical variation (Item 14) as evidence is needed to demonstrate that product will continue to meet the safety and efficacy criteria.

The following table examines each assessment module and provides an explanation of what modular assessments, levels, timeframe and associated fees are likely to apply to this extension. Modules 1, 11 and 12 are mandatory modules for this application.

Module type

Module level

Timeframe

Fee

1: Preliminary assessment

1.0

Up to one month

$902

2: Chemistry

No assessment required as the product is currently registered and no change is proposed to the product chemistry.

3: Toxicology

No assessment required as the product is currently registered and relevant health standards are already established. No new information provided.

4: Toxicology – Poison scheduling

No assessment required if appropriate scheduling is already in place.

5: Residues and trade

No assessment required as the use is a non-food use. Assessment of the residues at the site of injection would be required for a food producing species.

6: Work health and safety

No assessment is required as human exposure is not expected to change as a result of the variation.

7: Environment

No assessment is required as the overall exposure to the environment is not expected to change.

8: Efficacy and safety

Assessment is required to demonstrate that the new route of administration is safe and effective.

8.2

4 months

$1 950

9: Non-food trade

No assessment required as there are no changes to product risks to non-food trade.

10: Special data

No assessment required as the product is not an antibiotic or GMO.

11: Finalisation

11.2

2 months

$3 090

12: Limits on use (data protection)

12.0

N/A

$460

Total

 

6 months

$6 402

Start an application

If you want to vary your product to change a dose rate or frequency, and a technical variation (Item 14) is required:

You will be redirected to online services to log in.